Difference between revisions of "Resource:19344715-932f-4599-b6db-cef280258d52"

From The Embassy of Good Science
(Created page with "{{Resource |Resource Type=Cases |Title=The ethics of pharmaceutical research funding: A social organization approach |Is About=. |Important Because=. |Important For=Researcher...")
 
 
(7 intermediate revisions by 4 users not shown)
Line 1: Line 1:
 
{{Resource
 
{{Resource
 
|Resource Type=Cases
 
|Resource Type=Cases
|Title=The ethics of pharmaceutical research funding: A social organization approach
+
|Title=The Ethics of Pharmaceutical Research Funding: A Social Organization Approach
|Is About=.
+
|Is About=This is a fictional case about a researcher that works for a pharmaceutical company. Instead of looking from the viewpoint of the individual, the case adopts a ‘social organization approach’: it analyses how the interactions with the company personnel may subtly lead to unethical behaviour.  
|Important Because=.
+
<references responsive="0" />
 +
|Important Because=Studies that are financed by the pharmaceutical industry may be subject to a conflict of interest of the company. Routine contacts of the pharmaceutical company and the scientists may cause the scientist to perceive the unethical behaviour as normal. Adopting this new ‘social organization approach’, rather than analysing the individual characters, may give insight into how these company-scientist interactions can lead to unethical behaviour. Therefore, this case may potentially help us to prevent future unethical behaviour in pharmaceutical industry-sponsored studies.<br />
 +
<references />
 
|Important For=Researchers
 
|Important For=Researchers
 
}}
 
}}
Line 9: Line 11:
 
|Has Link=https://journals.sagepub.com/doi/10.1111/jlme.12072
 
|Has Link=https://journals.sagepub.com/doi/10.1111/jlme.12072
 
}}
 
}}
{{Related To}}
+
{{Related To
 +
|Related To Theme=Theme:92439f75-5c0c-49d4-a21f-e9b41bd3a7db
 +
}}
 
{{Tags
 
{{Tags
 
|Has Virtue And Value=Honesty
 
|Has Virtue And Value=Honesty

Latest revision as of 13:56, 5 August 2021

Cases

The Ethics of Pharmaceutical Research Funding: A Social Organization Approach

What is this about?

This is a fictional case about a researcher that works for a pharmaceutical company. Instead of looking from the viewpoint of the individual, the case adopts a ‘social organization approach’: it analyses how the interactions with the company personnel may subtly lead to unethical behaviour.

Why is this important?

Studies that are financed by the pharmaceutical industry may be subject to a conflict of interest of the company. Routine contacts of the pharmaceutical company and the scientists may cause the scientist to perceive the unethical behaviour as normal. Adopting this new ‘social organization approach’, rather than analysing the individual characters, may give insight into how these company-scientist interactions can lead to unethical behaviour. Therefore, this case may potentially help us to prevent future unethical behaviour in pharmaceutical industry-sponsored studies.

For whom is this important?

Other information

Virtues & Values
Good Practices & Misconduct
Research Area
Cookies help us deliver our services. By using our services, you agree to our use of cookies.
5.1.6